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Abstract
Background: Pleural infection is a common clinical problem. Its successful treatment depends on rapid diagnosis
and early initiation of antibiotics. The measurement of soluble triggering receptor expressed in myeloid cells-1
(sTREM-1) level in pleural effusions has proven to be a valuable diagnostic tool for differentiating bacterial effusions
from effusions of other etiologies. Herein, we performed a meta-analysis to assess the accuracy of pleural fluid
sTREM-1 in the diagnosis of bacterial infection.
Methods: We searched Web of Knowledge and Medline from 1990 through March 2011 for studies reporting
diagnostic accuracy data regarding the use of sTREM-1 in the diagnosis of bacterial pleural effusions. Pooled
sensitivity and specificity and summary measures of accuracy and Q* were calculated.
Results: Overall, the sensitivity of sTREM-1was 78% (95% CI: 72%-83%); the specificity was 84% (95% CI: 80%-87%);
the positive likelihood ratio was 6.0 (95% CI: 3.3-10.7); and the negative likelihood ratio was 0.22 (95% CI: 0.12-0.40).
The area under the SROC curve for sTREM-1 was 0.92. Statistical heterogeneity and inconsistency were found for
sensitivity (p = 0.015, c
2 = 15.73, I
2 = 61.9%), specificity (p = 0.000, c
2 = 29.90, I
2 = 79.9%), positive likelihood ratio
(p = 0.000, c
2 = 33.09, I
2 = 81.9%), negative likelihood ratio (p = 0.008, c
2 = 17.25, I
2 = 65.2%), and diagnostic odds
ratio (p = 0.000, c
2 = 28.49, I
2 = 78.9%). A meta-regression analysis performed showed that the Quality Assessment
of Diagnostic Accuracy Studies score (p = 0.3245; RDOR, 4.34; 95% CI, 0.11 to 164.01), the Standards for Reporting
of Diagnostic Accuracy score (p = 0.3331; RDOR, 1.70; 95% CI, 0.44 to 6.52), lack of blinding (p = 0.7439; RDOR, 0.60;
95% CI, 0.01 to 33.80), and whether the studies were prospective or retrospective studies (p = 0.2068; RDOR, 7.44;
95% CI, 0.18 to 301.17) did not affect the test accuracy. A funnel plot for publication bias suggested a remarkable
trend of publication bias.
Conclusions: Our findings suggest that sTREM-1 has a good diagnostic accuracy and may provide a useful
adjunctive tool for the diagnosis of bacterial pleural effusions. However, further studies are needed in order to
identify any differences in the diagnostic performance of sTREM-1 of parapneumonic effusions and empyemas.
Background
Pleural infection (parapneumonic effusion and
empyema) or bacterial pleural effusion is a common
clinical problem. Its successful treatment depends on
rapid diagnosis and early intiation of antibiotics. Delay
in diagnosis results in substantial delay in the com-
mencement of treatment and may contribute to the
high mortality of this infection. Treatment of all patients
with suspected pleural effusion with antibiotics while
awaiting for microbiological results is not a good option
since this practice increases antibiotic resistance. It is
surprising how, in many cases, even the diagnosis and
differential diagnosis of parapneumonic effusions poses
great problem. Biochemical parameters are often non-
specific and Gram stain has a low sensitivity. Pleural
fluid cultures, even though being specific, may take days
to reveal a positive culture and in 30% to 35% of cases,
the organism fails to be cultured [1].
The triggering receptor expressed in myeloid cells-1
(TREM-1) belongs to the immunoglobin superfamily
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exists in both a membranous and a soluble form (solu-
ble triggering receptor expressed on myeloid cells-1;
sTREM-1) [4]. TREM-1 is shed by the membrane of
activated phagocytes after exposure to bacteria and
fungi and, its soluble form, sTREM-1 can be detected in
body fluids [5,6]. The measurement of sTREM-1 level in
pleural effusions has proven to be a valuable diagnostic
tool for differentiating bacterial effusions from effusions
of other etiologies [7].
Up to now, no meta-analysis has been undertaken to
evaluate the accuracy of pleural fluid sTREM-1 in the
diagnosis of pleural effusions. We therefore conducted a
meta-analysis of the published literature to assess the
accuracy of pleural fluid sTREM-1 for the diagnosis of
pleural infection.
Methods
Study eligibility
Studies were considered eligible for inclusion in the
meta-analysis if they fulfilled the following criteria: origi-
nal publication; study population included human sub-
jects only; sensitivity and specificity of pleural fluid
sTREM-1 for the detection of bacterial infection in
pleural effusions could be calculated for patients with
proven bacterial effusions.
Literature search
Literature search was carried out using electronic data-
bases Web of Knowledge (1990 to March 2011) and
Medline (1990 to March 2011), with the databases being
last assessed on 28 March 2011. We used the terms
“sTREM-1”, “soluble triggering receptor expressed on
myeloid cells-1”, “parapneumonic effusion”, “empyema”,
“pleural fluid”, and “pleural effusion”, whereas the syntax
used for Medline searches was (("Pleural Effusion"[-
Mesh]) OR “Empyema, Pleural"[Mesh]) AND “ soluble
triggering receptor expressed on myeloid cells 1 protein,
human”. The search was restricted to human subjects.
Studies published only in abstract form were excluded
due to the fact that these studies had not undergone
peer-review and the inclusion of these studies might
introduce bias into the meta-analysis. Case reports,
review articles, and textbook chapters were also
excluded. The reference lists of all articles reviewed
were also searched for eligible studies.
Study selection and data extraction
Studies were included if they reported the sensitivity and
specificity of pleural fluid sTREM-1 in the diagnosis of
parapneumonic effusions and/or empyemas. Two
authors (HS and LLT) independently reviewed the
abstracts of all the studies generated by the computer-
ized search of Web of Knowledge and Medline. The full
text articles of all eligible abstracts were reviewed by the
two authors. Any discrepancies were resolved by discus-
sion with a third author to reach a final consensus. The
data extracted included: (1) publication details including
year of publication, title, name of the first author; (2)
type of study design (prospective/retrospective); (3)
study population; (4) sample size; (5) type of bacterial
pleural effusions (parapneumonic effusions and/or
empyema); (6) blinding of investigators to results; (7)
prevalence of bacterial effusions; (8) assay method; (9)
means of diagnosis of bacterial effusions; (10) any cut-
off value reported; (11) true positive, true negative, false
positive and false negative results; (12) any presence of
bias that may have influenced results including incor-
poration bias (i.e., using pleural fluid sTREM-1 as part
of the diagnostic criteria for bacterial effusions).
Study quality assessment
We used the Quality Assessment Tool for Diagnostic
Accuracy Studies (QUADAS tool) [8] and the Standards
for Reporting of Diagnostic Accuracy (STARD) checklist
[9] for the reporting of studies of diagnostic accuracy
for the assessment of the methodological quality of the
included studies.
Data analysis
We performed a diagnostic test accuracy meta-analysis
in order to determine the overall sensitivity and specifi-
city of pleural fluid sTREM-1 in the diagnosis of bacter-
ial effusions. Specifically, we used a bivariate random
effects model in order to calculate the pooled sensitivity
and specificity, pooled positive and negative likelihood
r a t i o[ 1 0 ] ,a sw e l la st h ed i a g n o s t i co d d sr a t i o ,a l o n g
with the respective 95% confidence intervals (CI). We
also constructed the summary receiver operating charac-
teristics curve (SROC) [11] and we calculated the
respective area under the curve (AUC). We also calcu-
lated Q*, where sensitivity = specificity on the summary
ROC curve, corresponding to the upper left-most point
o nt h eS R O C .T h ed e g r e eo fb e t ween-studies statistical
heterogeneity was evaluated with the use of the I
2 test
for the diagnostic odds ratio [12]. The presence of a
threshold effect on the diagnostic accuracy of pleural
fluid sTREM-1 was evaluated with the Spearman corre-
lation coefficient between thel o g i t so fs e n s i t i v i t ya n d
specificity. We also performed meta-regression analyses
in order to the effect of potentially confounding vari-
ables. The presence of publication bias was tested using
funnel plots and the Egger test [13]. A p value < 0.05
was considered as indicative of statistical significance.
All statistical analyses were performed using the follow-
ing statistical software programs: Stata, version 10.0;
Stata Corporation; College Station, TX; Meta-Disc for
Windows; XI Cochrane Colloquium; Barcelona, Spain.
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1. Description of studies
The initial database search revealed 35 articles. From
these 35 articles, 20 were excluded on the basis of title
and abstract for being irrelevant to our study question,
leaving 15 potentially relevant studies. Full articles of
potentially eligible studies were reviewed in depth and
finally 5 individual studies met our inclusion criteria
[14-18]. 2 studies were further identified [19,20] from
the reference lists of the 15 potentially relevant studies.
Figure 1 shows the study selection process.
Table 1 and Table 2 summarize the main characteris-
tics and results of the 7 included studies. A total of 733
patients were included in the meta-analysis. All the stu-
dies except one [17] were prospective studies. The
means of diagnosis of bacterial pleural effusions, that is,
the reference standard used in the studies included clini-
cal and radiological findings, laboratory results, Gram-
stain results, culture results and response to antibiotic
therapy. 2 studies reported data for parapneumonic effu-
sions only [19,20], 1 reported for empyemas only [16]
and the rest reported for both parapneumonic effusions
and empyemas. 2 studies [16,17] reported whether the
assessment was done in a blinded manner, whereas that
information was not reported in the other 5 studies.
The cut-off values ranged from 50 pg/mL to 768.1 pg/
mL. Enzyme-Linked Immunosorbent Assay (ELISA) was
used for pleural fluid sTREM-1 measurements in all 7
studies. 1 study [14] also reported the measurement of
surface TREM-1 by flow cytometry. Another study [15]
reported concentrations of sTREM-1 in both pleural
effusions and sera.
2. Methodological quality of the included studies
In Figure 2, we summarize the findings of the methodo-
logically quality assessment for the total of 7 studies
 
20 Studies excluded on the basis 
of title and abstract because they 
were considered as not relevant 
to study question 
10 studies excluded  
  8 were unsuitable 
  2 did not include sensitivity 
and specificity of the assay 
35 studies in database 
search 
15 potentially relevant 
studies identified 
5 studies were considered 
eligible for inclusion in the meta-
analysis 
7 studies included
2 studies included  
from reference lists 
Figure 1 Study selection process.
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We attributed a score of 1 point for each “yes”,0p o i n t
for each “no” and 0.5 point for each “unclear”. The max-
imum score using the QUADAS tool is 14.
The results of the methodological quality assessment
of the studies included in the meta-analysis using the
STARD checklist are shown in Table 3. The maximum
score using the STARD checklist is 25.
3. Diagnostic accuracy of sTREM-1 for the detection of
bacterial effusions
The pooled (95% CI) sensitivity of pleural fluid sTREM-
1 was 78% (72%-83%) and the pooled specificity was
84% (80%-87%). The pooled (95% CI) positive likelihood
ratio was 6.0 (3.3-10.7), the negative likelihood ratio was
0.22 (0.12-0.40), and the diagnostic odds ratio was 33
(10-104). (Figure 3)
4. Threshold analysis and Summary Receiver-Operating
Characteristics
A ss h o w ni nF i g u r e4 ,ap o s i t i ve correlation was noted
between sensitivities and 1-specificities. The Q* value,
representing the highest common value of sensitivity
and specificity was 0.854 (SE, 0.0383) and the area
under the curve (AUC) was 0.92 (SE, 0.0333), indicating
excellent diagnostic accuracy. No statistically significant
difference was observed when exploring for threshold
effect (n = 52, Spearman correlation coefficient = -0.643;
p = 0.119).
5. Nomogram for likelihood ratios
Figure 5 represents the nomogram for likelihood ratios,
derived from the Fagan nomogram [21] and was gener-
ated by a web-based tool [22]. With a hypothetical pre-
test probability of 37%, using pleural fluid sTREM-1 for
Table 1 Characteristics of studies included in the meta-analysis
STUDY/
YEAR
COUNTRY STUDY
POPULATION
AGE STUDY
DESIGN
BLINDING OF
INVESTIGATORS
MEANS OF DIAGNOSIS OF
BACTERIAL EFFUSIONS
TYPE OF
BACTERIAL
INFECTION
ASSAY
METHOD
Chan et al./
2007
Taiwan ICU/
hospital ward
NR prospective NR clinical and biochemical findings;
radiological studies; Gram stain;
culture
10 PPE and
12 empyemas
ELISA
Kim et al./
2007
Korea Hospital ward > 18 prospective NR clinical and biochemical findings;
radiological studies; culture;response
to antibiotic therapy
17 PPE ELISA
Sim et al./
2007
Korea Hospital ward NR prospective NR clinical and biochemical findings;
radiological studies; culture;response
to antibiotic therapy
15 PPE ELISA
Huang
et al./2008
China Hospital ward 17-81 prospective NR clinical and biochemical findings;
radiological studies; culture;response
to antibiotic therapy
4 PPE and 17
empyemas
ELISA
Bishara
et al./2009
Israel ICU/
hospital ward
NR prospective Yes clinical and biochemical findings;
Gram stain; culture
17 empyemas ELISA
Porcel
et al./2009
Spain ICU/
hospital ward
NR retrospective Yes clinical and biochemical findings;
radiological studies; culture;response
to antibiotic therapy
128 PPE and
30 empyemas
ELISA
Determann
et al./2010
The
Netherlands
ICU NR prospective NR clinical findings; Light’s criteria;
bacterial culture,response to antibotic
therapy
5 PPE and 11
empyemas
ELISA
PPE: Parapneumonic effusions; ELISA: Enzyme linked immunosorbent assay
Table 2 Results of studies included in meta-analysis
STUDY/YEAR NUMBER OF PATIENTS (n) PREVALENCE OF BACTERIAL EFFUSIONS (%) CUT-OFF (pg/mL) TP FP FN TN
Chan et al./2007 67 33 374 21 4 1 41
Kim et al./2007 48 35 55.4 12 8 5 23
Sim et al./2007 45 49 103.5 16 4 6 19
Huang et al./2008 109 19 768.1 18 6 3 82
Bishara et al./2009 89 19 114 16 5 1 67
Porcel et al./2009 308 50 80 115 42 43 108
Determann et al./2010 67 24 50 15 7 1 44
TP: True Positive; FP: False Positive; FN: False Negative; TN: True Negative.
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test probability to 74%. With a negative likelihood ratio
of 0.2, using pleural fluid sTREM-1 reduces the post-
test probability to 13%.
6. Investigation of heterogeneity
The Chi-square test was used to evaluate the presence
of statistically significant heterogeneity across the studies
and the inconsistency index (I-squared) was used to
quantify the amount of heterogeneity. Statistical hetero-
geneity and inconsistency were found for sensitivity (p =
0.015, c
2 = 15.73, I
2 = 61.9%), specificity (p = 0.000, c
2
= 29.90, I
2 = 79.9%), positive LR (p = 0.000, c
2 = 33.09,
I
2 = 81.9%), negative LR (p = 0.008, c
2 = 17.25, I
2 =
65.2%), and DOR (p = 0.000, c
2 = 28.49, I
2 = 78.9%).
7. Meta-Regression analysis
We chose to investigate whether the QUADAS score,
the STARD score, lack of blinding, and whether the stu-
dies were prospective or retrospective studies were
responsible for the heterogeneity noted. The meta-
regression analysis we performed showed that the QUA-
DAS score (p = 0.3245; RDOR, 4.34; 95% CI, 0.11 to
164.01), the STARD score (p = 0.3331; RDOR, 1.70; 95%
Figure 2 Summary of the methodological quality assessment of the included studies. Bars filled with blue/red/green color indicate the
percentage of the studies that meet/do not meet the criteria/do not provide adequate relevant data, respectively.
Table 3 Summarized quality assessment using the STARD checklist
Section Maximum score for each
category
Study
Chan et
al.
[11]
Kim et al.
[16]
Sim et al.
[17]
Huang et al.
[12]
Bishara et al.
[13]
Porcel et al.
[14]
Determann
et al.
[15]
Title and
introduction
22 2 2 2 2 2 2
Methods 11 9 8 9 7 10 9 9
Results 11 5 5 5 8 7 6 8
Discussion 1 1 1 1 1 1 1 1
Total 25 17 16 17 18 20 18 20
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0.60; 95% CI, 0.01 to 33.80), and whether the studies
were prospective or retrospective studies (p = 0.2068;
RDOR, 7.44; 95% CI, 0.18 to 301.17) did not affect the
test accuracy.
8. Evaluation of publication bias
During the evaluation of publication bias, we found the
p value for the Egger test to be statistically significant (p
= 0.000). The funnel plot for publication bias (Figure 6)
also suggests asymmetry, indicating a remarkable trend
of publication bias.
Discussion
Bacterial pleural effusions present a challenge for both
diagnosis and treatment in many cases. Although signifi-
cant recent advances have been made in the diagnosis
and treatment of pleural infections, there still remains
the need for further research if we are to reduce the
morbidity and mortality caused by bacterial pleural
effusions.
sTREM-1 is a diagnostic marker for sepsis and inflam-
mation. It has been described as a diagnostic marker
with a high accuracy and sensitivity in detecting micro-
bial infections as underlying disease in critically ill
patients [6,23,24]. The levels of sTREM-1 have pre-
viously been investigated in plasma, bronchoalveolar
lavage fluid and exhaled breath [25-27]. In 2007, Liu et
al. investigated this biomarker in pleural fluids for the
first time and successfully demonstrated that it is a valu-
able marker in establishing the etiology of pleural effu-
sions [28]. In the very same year, Chan et al. showed
that pleural fluid sTREM-1 has a better diagnostic accu-
racy when compared to traditional parameters like
Sensitivity
0 0.2 0.4 0.6 0.8 1
Chan et al. [14] 0.95    (0.77 - 1.00
Kim et al. [15] 0.71    (0.44 - 0.90
Sim et al. [16] 0.73    (0.50 - 0.89
Huang et al. [17] 0.86    (0.64 - 0.97
Bishara et al. [18] 0.94    (0.71 - 1.00
Porcel et al. [19] 0.73    (0.65 - 0.80
Determann et al. [20] 0.94    (0.70 - 1.00
Sensitivity (95% CI)
Pooled Sensitivity = 0.78 (0.73 to 0.83)
Chi-square = 15.73; df =  6 (p = 0.0153)
Inconsistency (I-square) = 61.9 %
Specificity
0 0.2 0.4 0.6 0.8 1
Chan et al. [14] 0.91    (0.79 - 0.98
Kim et al. [15] 0.74    (0.55 - 0.88
Sim et al. [16] 0.83    (0.61 - 0.95
Huang et al. [17] 0.93    (0.86 - 0.97
Bishara et al. [18] 0.93    (0.85 - 0.98
Porcel et al. [19] 0.72    (0.64 - 0.79
Determann et al. [20] 0.86    (0.74 - 0.94
Specificity (95% CI)
Pooled Specificity = 0.83 (0.80 to 0.87)
Chi-square = 29.90; df =  6 (p = 0.0000)
Inconsistency (I-square) = 79.9 %
Positive LR
0.01 100.0 1
Chan et al. [14] 10.74    (4.20 - 27.4
Kim et al. [15] 2.74    (1.40 - 5.35)
Sim et al. [16] 4.18    (1.66 - 10.56
Huang et al. [17] 12.57    (5.69 - 27.7
Bishara et al. [18] 13.55    (5.77 - 31.8
Porcel et al. [19] 2.60    (1.98 - 3.42)
Determann et al. [20] 6.83    (3.39 - 13.75
Positiv e LR (95% CI)
Random Effects Model
Pooled Positive LR = 5.95 (3.30 to 10.74)
Cochran-Q = 33.09; df =  6 (p = 0.0000)
Inconsistency (I-square) = 81.9 %
Tau-squared = 0.4906
Negative LR
0.01 100.0 1
Chan et al. [14] 0.05    (0.01 - 0.34
Kim et al. [15] 0.40    (0.18 - 0.85
Sim et al. [16] 0.33    (0.16 - 0.67
Huang et al. [17] 0.15    (0.05 - 0.44
Bishara et al. [18] 0.06    (0.01 - 0.42
Porcel et al. [19] 0.38    (0.29 - 0.50
Determann et al. [20] 0.07    (0.01 - 0.48
Negativ e LR (95% C
Random Effects Model
Pooled Negative LR = 0.22 (0.12 to 0.40)
Cochran-Q = 17.25; df =  6 (p = 0.0084)
Inconsistency (I-square) = 65.2 %
Tau-squared = 0.3299
Diagnostic Odds Ratio
0.01 100.0 1
Chan et al. [14] 215.25    (22.61 - 2,049.4
Kim et al. [15] 6.90    (1.85 - 25.76)
Sim et al. [16] 12.67    (3.03 - 52.89)
Huang et al. [17] 82.00    (18.73 - 359.08)
Bishara et al. [18] 214.40    (23.40 - 1,964.6
Porcel et al. [19] 6.88    (4.17 - 11.34)
Determann et al. [20] 94.29    (10.70 - 830.50)
Diagnostic OR (95% CI)
Random Effects Model
Pooled Diagnostic Odds Ratio = 32.70 (10.32 to 103
Cochran-Q = 28.49; df =  6 (p = 0.0001)
Inconsistency (I-square) = 78.9 %
Tau-squared = 1.7317
A  B
E
D C
Figure 3 Forest plots of A. sensitivity, B.s p e c i f i c i t y ,C. positive likelihood ratio, D. negative likelihood ratio and E. diagnostic odds
ratio of pleural fluid sTREM-1 for the diagnosis of bacterial effusions.
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there have been several studies which have attempted to
evaluate the diagnostic accuracy of this novel biomarker.
In this regard, we performed this meta-analysis of 7
relevant studies in order to evaluate the accuracy of
pleural fluid sTREM-1 for the diagnosis of bacterial
pleural effusions. A total of 733 subjects were included
in the study.
According to our findings, pleural fluid sTREM-1
seems to have a good diagnostic accuracy for bacterial
pleural effusions since the area under the SROC curve
was 0.92 and the Q* value was 0.85. The pooled sensi-
tivity of pleural fluid sTREM-1 for the diagnosis of bac-
terial effusions was 78% and the specificity was 83%.
Pooled positive LR was 5.95. With a hypothetical pre-
test probability of 37%, using pleural fluid sTREM-1 for
the detection of bacterial effusion would raise the post-
test probability to 74%. With a negative likelihood ratio
of 0.2, using pleural fluid sTREM-1 reduces the post-
test probability to 13%, thereby showing that the appli-
cation of pleural fluid sTREM-1 test to pleural effusions
can be helpful in ruling out a bacterial pleural effusion.
An additional finding of our meta-analysis is that
while the pooled DOR was 32.7, some studies achieved
DOR as high as 215.2, while others attained a very low
DOR of 6.9. The DOR is a single indicator of test
accuracy [29]. The disparity noticed in our study can
result from a number of reasons, for example, differ-
ences in the nature of the study population, whether
they suffered from parapneumonic effusions or
empyema. Since pleural fluid sTREM-1 levels are upre-
gulated by the presence of endotoxins [30], we can sti-
pulate that empyemas, having a higher burden of
endotoxin will, most probably have a higher level of
sTREM-1. This is confirmed by the sensitivity and spe-
cificity values of pleural fluid sTREM-1 in the studies
included in our meta-analysis. Studies including
empyemas only, for example, the study carried out by
Bishara et al. [16] and those including a higher number
of empyemas than PPE, that is, the ones carried out by
Chan et al.[14], Huang et al. [15] and Determann et
al. [18] attained higher DORs as well as higher sensi-
tivities and specificities than those reporting pleural
fluid sTREM-1 levels in PPE only or having a larger
Sensitivity SROC Curve
1-specificity
0 0.2 0.4 0.6 0.8 1
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
Symmetric SROC
AUC = 0.9205
SE(AUC) = 0.0333
Q* = 0.8540
SE(Q*) = 0.0383
Q*-point 
Figure 4 Summary receiver operating characteristic (ROC) curve. Observed values at study level are displayed (triangles) where y is the
sensitivity and × is 1-specificity. The Q*-value sTREM-1 is 0.85 (SE 0.038).
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Page 7 of 11number of PPE than empyemas. The studies carried
out by Determann et al. and Bishara et al. were the
only two studies to provide details of the isolated
pathogens from pleural effusions. However, they did
not mention which organism cultured had the greatest
impact on pleural fluid sTREM-1. Moreover, one
patient from the study of Determann et al. and four
patients from the study of Bishara et al. with macro-
scopic empyema had negative culture results and high
pleural fluid sTREM-1 levels, thereby showing that
even though organisms fail to be cultured, pleural fluid
sTREM-1 is still high in pleural infection.
Although characteristics of patients and clinical set-
tings were similar, and the same reference standards
were adopted, there were marked differences in the size
of the study populations and in the prevalence of bacter-
ial effusions. Two studies reported higher prevalences as
compared to others [17,20]. Porcel et al. carried out a
retrospective study where they reported the samples to
have been randomly chosen out of all stored samples
from 2004 to 2008. The fact that not all bacterial pleural
effusions and samples during that time period were used
to calculate the prevalence might account for the high
prevalence in this study. Sim et al., on the other hand,
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Figure 5 Nomogram for likelihood ratios. The nomogram shown is derived from the Fagan nomogram. The left side of the figure indicates a
hypothetical pre-test probability of disease of 37%.
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reason for the high prevalence in this study.
Due to the fact that our meta-analysis revealed
marked heterogeneity with regard to sensitivity, specifi-
city, positive likelihood ratio, negative likelihood ratio
and diagnostic odds ratio, we undertook a meta-regres-
sion analysis to explore the possible reasons for this het-
erogeneity [31]. However, none of the variables included
in the meta-regression analysis were found to affect the
diagnostic accuracy of pleural fluid sTREM-1. The 7
studies included in the study were considered to be of
good quality, with the overall QUADAS score to be
above 10 for all the studies and a score above 15 for all
studies when using the STARD checklist. Despite the
fact that lack of blinding also was found not to affect
the diagnostic accuracy of pleural fluid sTREM-1 when
we carried out the meta-regression analysis, we stipu-
lated that heterogeneity might have partly attributed to
false negative test results which might have gone unde-
tected when there was no blinding. Additionally, the
type of study included (prospective or retrospective) was
not found to affect the diagnostic accuracy. This might
be due to the fact that, out of the 7 included studies,
only one was of retrospective nature. However, this one
study accounted for the largest number of subjects
included in the study, hence, a probable cause of
heterogeneity.
The results of our meta-analysis are reliable due to the
fact that even though the total number of studies
included was small, the number of patients enrolled was
satisfactory, hence decreasing Type II error. Addition-
ally, sTREM-1 levels decline with therapy [32]. The use
of antimicrobial therapy is likely to decrease the sensi-
tivity of sTREM-1. The studies included in our meta-
analysis reported sampling of pleural fluid for sTREM-1
analysis before the initiation of antimicrobial therapy.
Our analysis had limitations that should be considered
during interpretation of our findings. As mentioned ear-
lier, most of the studies did not report blind testing and
thus they were likely to overestimate accuracy, particu-
larly sensitivity, thus underscoring the need to improve
quality of design and reporting. Moreover, the lack of
blinding might have also affected the overall sensitivity
of the assay. It has been formerly proven that pleural
fluid sTREM-1 levels differ in PPE and empyema [17].
Yet, we did not compute data separately for PPE and
empyema due to the lack of data for each entity indivi-
dually. For this same reason, we did not calculate a cut-
0
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1
.
5
2
-2 0 2 4 6
Log odds ratio
Funnel plot with pseudo 95% confidence limits
Figure 6 Funnel plot for the assessment of potential publication bias in pleural fluid sTREM-1 for the diagnosis of bacterial effusions.
(The diagonal line represents Egger’s line).
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Page 9 of 11off value for pleural fluid sTREM-1. Our meta-analysis,
just like any other meta-analysis, could be influenced by
publication bias as shown by the asymmetrical funnel
plot in Figure 6[33,34]. Exclusion of case-reports, letters
to editors and conference abstracts might have contribu-
ted to publication bias. Usually, studies having positive
results have a greater tendency of being published and
those with no results are usually not published, thus
adding to publication bias in our analysis.
Conclusions
In conclusion, according to our findings, sTREM-1
seems to be a reliable marker for bacterial pleural effu-
sions since it has a good overall diagnostic performance.
However, due to the fact that cut-off values vary greatly
for parapneumonic effusions and empyemas, before
sTREM-1 can be used widely in the clinical setting,
more large blinded prospective studies must be carried
out in parapneumonic effusions and empyemas sepa-
rately to evaluate its accuracy.
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